IQVIA Holdings Inc.
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development…
What to know about IQV
IQVIA Holdings Inc. is a large Healthcare company with a mixed financial profile. It scores well on sentiment and valuation, but health is worth keeping an eye on.
Should you consider IQV?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
IQVIA Holdings Inc. is a large-cap Healthcare company with a mixed overall financial profile — it is in the lower half of its Healthcare peers (37 of 59).
-
Profitability is roughly average for the S&P 500 — not a standout in either direction.
-
Valuation looks attractive — the stock is priced reasonably relative to its earnings and sales compared to most peers. You're not overpaying for the business.
-
Growth has been slower than most peers. That's not necessarily a dealbreaker, but it means the investment case rests more on current earnings than future expansion.
-
This stock pays no dividend — your return depends entirely on the share price rising over time.
-
The stock is more volatile than most S&P 500 names — it can swing sharply in both directions. This suits investors comfortable with bigger short-term moves.
-
Analyst sentiment is broadly positive and short interest is low — professionals who cover this stock are mostly optimistic about its near-term prospects.
-
There are several areas of concern. This may suit investors with a higher risk tolerance or a specific contrarian view on the Healthcare sector.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how IQV compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 20.87 | Above avg |
| Forward P/E | 11.82 | Top 25% |
| PEG Ratio | 0.72 | Top 25% |
| Price to Sales | 1.68 | Top 25% |
| Price to Book | 4.50 | Average |
| EV/EBITDA | 14.71 | Above avg |
| Earnings Yield | 4.79% | Above avg |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 32.99% | Average |
| Operating Margin | 13.61% | Average |
| Net Profit Margin | 8.33% | Average |
| Return on Equity | 22.49% | Above avg |
| Return on Invested Capital | 5.13% | Average |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 8.40% | Average |
| Revenue Growth (3Y CAGR) | 4.21% | Average |
| EPS Growth (YoY) | 15.00% | Average |
| Free Cash Flow Growth | -2.98% | Average |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 0.75 | Below avg |
| Debt to Equity | 2.55 | Below avg |
| Interest Coverage | 3.18 | Below avg |
| Altman Z-Score | 1.78 | Below avg |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | — | N/A |
| Payout Ratio | — | N/A |
| Dividend Growth (5Y) | — | N/A |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 7.56% | Top 25% |
| OCF to Sales | 16.26% | Average |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 1.22 | Average |
| Volatility (30-Day) | 40.96% | Average |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 3.40% | Above avg |
| Avg. Analyst Rating | 1.36 | Top 25% |
| Target Upside % | 35.27% | Top 25% |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 28B | Average |
How does IQV compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to IQV — based on their financial profile.